Recent advances in antiviral nucleoside and nucleotide therapeutics

被引：53
作者：
Simons, C
Wu, QP
Htar, TT
机构：
[1] Cardiff Univ, Welsh Sch Pharm, Div Med Chem, Cardiff CF10 3FX, S Glam, Wales
[2] Beijing Inst Technol, Sch Life Sci & Technol, Beijing 100081, Peoples R China
[3] Univ Coll Sedaya Int, Sch Pharm, Kuala Lumpur 56100, Malaysia
来源：
CURRENT TOPICS IN MEDICINAL CHEMISTRY | 2005年 / 5卷 / 13期
关键词：
nucleoside/nucleotide therapeutics; influenza virus; human immunodeficiency virus; hepatitis B and C virus; herpes virus; poxvirus; filovirus; siRNA; antisense oligonucleotides;
D O I：
10.2174/156802605774463051
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Recent developments in nucleoside/nucleotide therapeutics and antiviral drug targets are described covering progress in the development of nucleoside/nucleotide mimetics for the treatment of influenza virus, human immunodeficiency virus type 1, hepatitis B and C virus, herpes virus infections; including herpes simplex virus, cytomegalovirus and varicella zoster virus infections, and the highly pathogenic poxviruses (variola, vaccinia and mokey pox) and filoviruses (Ebola and Marburg).
引用
收藏
页码：1191 / 1203
页数：13
相关论文
共 91 条
  • [1] Susceptibilities of several clinical Varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides
    Andrei, G
    Sienaert, R
    McGuigan, C
    De Clercq, E
    Balzarini, J
    Snoeck, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 1081 - 1086
  • [2] [Anonymous], AIDS EP UPD
  • [3] Pharmacokinetics of the antiviral agent β-L-3′-fluoro-2′,3′-didehydro-2′,3′-dideoxycytidine in rhesus monkeys
    Asif, G
    Hurwitz, SJ
    Gumina, G
    Chu, CK
    McClure, HM
    Schinazi, RF
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 560 - 564
  • [4] Bicyclic pyrimidine nucleoside analogues (BCNAs) as highly selective and potent inhibitors of varicella-zoster virus replication
    Balzarini, J
    McGuigan, C
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 5 - 9
  • [5] Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action
    Biron, KK
    Harvey, RJ
    Chamberlain, SC
    Good, SS
    Smith, AA
    Davis, MG
    Talarico, CL
    Miller, WH
    Ferris, R
    Dornsife, RE
    Stanat, SC
    Drach, JC
    Townsend, LB
    Koszalka, GW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2365 - 2372
  • [6] Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases
    Boyer, PL
    Julias, JG
    Marquez, VE
    Hughes, SH
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2005, 345 (03) : 441 - 450
  • [7] Efficacy of oral active ether lipid analogs of cidofovir in a lethal mousepox model
    Buller, RM
    Owens, G
    Schriewer, J
    Melman, L
    Beadle, JR
    Hostetler, KY
    [J]. VIROLOGY, 2004, 318 (02) : 474 - 481
  • [8] The evolving field of biodefence: Therapeutic developments and diagnostics
    Burnett, JC
    Henchal, EA
    Schmaljohn, AL
    Bavari, S
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (04) : 281 - 297
  • [9] Camarasa MJ, 2004, CURR TOP MED CHEM, V4
  • [10] EFFECTS OF RIBAVIRIN ON RED-BLOOD-CELLS
    CANONICO, PG
    KASTELLO, MD
    SPEARS, CT
    BROWN, JR
    JACKSON, EA
    JENKINS, DE
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1984, 74 (02) : 155 - 162
12345678910